Skip to main content
OpenTrials

Clinical trial condition

Neurofibromatosis 2

Explore clinical trials studying Neurofibromatosis 2. Study availability and eligibility vary by location and protocol.

36 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Neurofibromatosis 2 trial results

Completed

Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas

NCT01767792

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +26 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Children's HealthCare of Atlanta Atlanta, Georgia, United States
  • University of Chicago Chicago, Illinois, United States
View Trial Details
Completed

Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas

NCT01125046

Conditions
Acoustic Schwannoma, Adult Anaplastic Meningioma, Adult Ependymoma, +51 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Columbia University Medical Center New York, United States
  • University of Virginia Charlottesville, Virginia, United States
View Trial Details
Completed

Concentration and Activity of Lapatinib in Vestibular Schwannomas

NCT00863122

Conditions
Acoustic Neuroma, Auditory Tumor, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +31 more
Locations
  • House Reserach Institute Los Angeles, California, United States
  • Johns Hopkins Hospital Baltimore, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Washington University Medical Center St Louis, Missouri, United States
View Trial Details

Related conditions